OBJECTIVES: Rapid growth velocity in early life may be a risk factor for obesity, elevated blood pressure, and adverse metabolic markers in childhood, but results are not consistent. We analysed the association between peak growth velocity during the first 2 years of life and blood pressure, fasting glucose and insulin at 10 years of age. METHODS: A prospective German birth cohort (LISAplus) provided data on growth, blood pressure, glucose, and insulin for 1127 children up to the age of 10 years. All children had a birth weight of at least 2500 g. Growth was modelled using nonlinear mixed-effect Reed1 models. Associations between peak growth velocities and metabolic outcomes were calculated with linear regression models. Potential confounders were sequentially adjusted for. RESULTS: Higher peak height velocity (PHV) and peak weight velocity (PWV) in infancy were associated with significant increase in systolic blood pressure (SBP) and diastolic blood pressure (DBP) in children at 10 years. For each 10.2 cm/year [2 standard deviation (SD)] increase in PHV, SBP increased by 2.94 mmHg [95% confidence interval (CI) 1.34, 4.54] after adjustment for potential confounders including birth weight and body mass index. A 5.1 kg/year (2 SD) higher PWV was associated with a 2.13 mmHg (95% CI 0.51, 3.74) increase in SBP and a 1.91 mmHg (95% CI 0.52, 3.30) increase in DBP. No consistent associations were found between PHV or PWV and the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index after multiple adjustments. CONCLUSIONS: Blood pressure and metabolic outcomes at school age may be associated with growth patterns in early life, regardless of relative weight during school age.
OBJECTIVES: Rapid growth velocity in early life may be a risk factor for obesity, elevated blood pressure, and adverse metabolic markers in childhood, but results are not consistent. We analysed the association between peak growth velocity during the first 2 years of life and blood pressure, fasting glucose and insulin at 10 years of age. METHODS: A prospective German birth cohort (LISAplus) provided data on growth, blood pressure, glucose, and insulin for 1127 children up to the age of 10 years. All children had a birth weight of at least 2500 g. Growth was modelled using nonlinear mixed-effect Reed1 models. Associations between peak growth velocities and metabolic outcomes were calculated with linear regression models. Potential confounders were sequentially adjusted for. RESULTS: Higher peak height velocity (PHV) and peak weight velocity (PWV) in infancy were associated with significant increase in systolic blood pressure (SBP) and diastolic blood pressure (DBP) in children at 10 years. For each 10.2 cm/year [2 standard deviation (SD)] increase in PHV, SBP increased by 2.94 mmHg [95% confidence interval (CI) 1.34, 4.54] after adjustment for potential confounders including birth weight and body mass index. A 5.1 kg/year (2 SD) higher PWV was associated with a 2.13 mmHg (95% CI 0.51, 3.74) increase in SBP and a 1.91 mmHg (95% CI 0.52, 3.30) increase in DBP. No consistent associations were found between PHV or PWV and the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index after multiple adjustments. CONCLUSIONS: Blood pressure and metabolic outcomes at school age may be associated with growth patterns in early life, regardless of relative weight during school age.
Authors: Tamara Marinkovic; Liza Toemen; Claudia J Kruithof; Irwin Reiss; Lennie van Osch-Gevers; Albert Hofman; Oscar H Franco; Vincent W V Jaddoe Journal: J Pediatr Date: 2017-02-28 Impact factor: 4.406
Authors: Juan M Castro; Victoria García-Espinosa; Agustina Zinoveev; Mariana Marin; Cecilia Severi; Pedro Chiesa; Daniel Bia; Yanina Zócalo Journal: J Cardiovasc Dev Dis Date: 2019-09-06
Authors: Alexessander Couto Alves; N Maneka G De Silva; Ville Karhunen; Ulla Sovio; Shikta Das; H Rob Taal; Nicole M Warrington; Alexandra M Lewin; Marika Kaakinen; Diana L Cousminer; Elisabeth Thiering; Nicholas J Timpson; Tom A Bond; Estelle Lowry; Christopher D Brown; Xavier Estivill; Virpi Lindi; Jonathan P Bradfield; Frank Geller; Doug Speed; Lachlan J M Coin; Marie Loh; Sheila J Barton; Lawrence J Beilin; Hans Bisgaard; Klaus Bønnelykke; Rohia Alili; Ida J Hatoum; Katharina Schramm; Rufus Cartwright; Marie-Aline Charles; Vincenzo Salerno; Karine Clément; Annique A J Claringbould; Cornelia M van Duijn; Elena Moltchanova; Johan G Eriksson; Cathy Elks; Bjarke Feenstra; Claudia Flexeder; Stephen Franks; Timothy M Frayling; Rachel M Freathy; Paul Elliott; Elisabeth Widén; Hakon Hakonarson; Andrew T Hattersley; Alina Rodriguez; Marco Banterle; Joachim Heinrich; Barbara Heude; John W Holloway; Albert Hofman; Elina Hyppönen; Hazel Inskip; Lee M Kaplan; Asa K Hedman; Esa Läärä; Holger Prokisch; Harald Grallert; Timo A Lakka; Debbie A Lawlor; Mads Melbye; Tarunveer S Ahluwalia; Marcella Marinelli; Iona Y Millwood; Lyle J Palmer; Craig E Pennell; John R Perry; Susan M Ring; Markku J Savolainen; Fernando Rivadeneira; Marie Standl; Jordi Sunyer; Carla M T Tiesler; Andre G Uitterlinden; William Schierding; Justin M O'Sullivan; Inga Prokopenko; Karl-Heinz Herzig; George Davey Smith; Paul O'Reilly; Janine F Felix; Jessica L Buxton; Alexandra I F Blakemore; Ken K Ong; Vincent W V Jaddoe; Struan F A Grant; Sylvain Sebert; Mark I McCarthy; Marjo-Riitta Järvelin Journal: Sci Adv Date: 2019-09-04 Impact factor: 14.136
Authors: Marieke L A de Hoog; Manon van Eijsden; Karien Stronks; Reinoud J B J Gemke; Tanja G M Vrijkotte Journal: PLoS One Date: 2012-08-20 Impact factor: 3.240
Authors: Iana Markevych; Elisabeth Thiering; Elaine Fuertes; Dorothea Sugiri; Dietrich Berdel; Sibylle Koletzko; Andrea von Berg; Carl-Peter Bauer; Joachim Heinrich Journal: BMC Public Health Date: 2014-05-20 Impact factor: 3.295